New Delhi: CSIR, the country’s premier research organization, is aiming to tap the multimillion- dollar Intellectual property rights market by commercializing its patents and leasing it to different industrial bodies, including drug makers.
Council for Scientific and Industrial Research (CSIR), which has around 38 research and development laboratories across the country, is mulling to commercialize its patent system, and going a step further, planning to tie up with some professional bodies.
“We are working on the different models (of patent business) to commercialize our patent system, which has a huge potential to become a good source of income for the organisation,” CSIR director general Samir K Brahmachari told PTI.
Headed by the Prime Minister, CSIR is one of the world’s largest publicly funded R&D organizations and has linkages with academia, R&D organizations and industry. Prime Minister of India is the ex-officio President of CSIR.
CSIR, an autonomous body set up through the acts of the parliament is aiming to tap billion-dollar markets from its innovations by leasing its patents to potential buyers like drug manufactures and other industrial bodies.
When asked about the volume of patent granted and number of patent application, he said CSIR was one of the biggest application filer in the country. However, he also admitted that some of their patents were not up to the level.
CSIR generates a number of the inventions annually but the quality of these innovations is not so high, which is a matter of concern for the authorities.